乙类受体C型2:作用和药物标
Lan Sun1,2, Zhe Wang1,3, Zhiyan Liu1,3
1Department of Pharmacy, Peking University First Hospital, No. 6, Da Hong Luo Chang Street, Xicheng District, Beijing, 100034, China.
血小板上的C型甲状腺样受体-2 (CLEC-2) 结合了波多普拉宁等配体,影响了血栓形成和癌症. 针对这种相互作用为血栓栓塞性疾病和癌症治疗提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 甲型甲酸样受体-2 (CLEC-2) 是细胞表面受体,表达在血小板上.
- CLEC-2与内源性 (波多普拉宁) 和外源性 (罗多西丁) 连接物相互作用.
- 这种相互作用在血小板激活和聚合中起作用.
研究的目的:
- 审查CLEC-2及其配体在各种病理生理过程中的作用.
- 讨论针对CLEC-2-podoplanin相互作用的治疗潜力.
- 突出与CLEC-2相关的诊断和治疗方面的进展.
主要方法:
- 对CLEC-2功能和相互作用研究的文献综述.
- 对CLEC-2在动脉样硬化,癌症和血栓形成等疾病中的参与进行分析.
- 检查针对CLEC-2及其配体的治疗策略.
主要成果:
- CLEC-2及其连接物与动脉样硬化,癌症,炎症性血栓和血管完整性有关.
- 已开发出抗波多普拉宁抗体用于癌症治疗 (例如质母细胞瘤,肺癌).
- 在病态状态下,CLEC-2会调解血栓形成,但其删除不会影响正常的血静.
结论:
- 这种CLEC-2-podoplanin相互作用是癌症治疗的一个有希望的目标.
- 准CLEC-2为血栓栓塞性疾病提供了潜在的治疗应用.
- CLEC-2具有临床应用和在各种疾病中发挥治疗作用的潜力.
更多相关视频
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Selectins
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
